Click here to read the expert reaction to the BMJ article: Click here to read the BMJ article: Science Media Centre University of East London Wegovy(semaglutide) HCP Mounjaro (tirzepatide) HCP To view or add a comment, sign in Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life and few show cardiovascular benefits at one year, finds a new study in The BMJ Greater weight loss was consistently accompanied by higher rates of side effects and treatment discontinuation, which the authors say indicates a clear benefit-harm trade-off
It comes as a tablet (Rybelsus) or an injection (Ozempic) and is available on the NHS
Our team specializes in hormonal disorders, including diabetes, as well as weight loss management
Thats why this prep schedule is designed to be shorter and less physically demanding than a standard meal prep session
Before you let the science-y names scare you off, lets unpack what these medications actually do, how they differ, and why both are excellent choices depending on your needs
Increases HDL Cholesterol In some studies, Semaglutide has been associated with a modest increase in HDL (good) cholesterol, further supporting cardiovascular health
